Background: A distinct type of pancreatitis associated with diabetes, termed fibrocalculous pancreatic diabetes (FCPD), has been reported in tropical developing countries including Bangladesh. The molecular basis for autosomal dominant hereditary pancreatitis (HP) has recently been attributed to mutations in exons 2 and 3 of the trypsinogen gene. We have investigated the hypothesis that mutations in the aforementioned exons of this gene might also predispose to FCPD. Methods: Seventy Bangladeshi and 50 South Indian unrelated FCPD patients and seven South Indian families with FCPD probands were studied. Pancreatic calcification was confirmed by abdominal X-ray, ultrasound and/or ERCP. Established mutations of exons 2 and 3 of the trypsinogen...
OBJECTIVE The pathogenesis of chronic pancreatitis (CP) is poorly understood. Genetic studies revea...
OBJECTIVES: Cystic fibrosis transmembrane conductance regulator (CFTR), cationic trypsinogen gene (P...
Several missense mutations, including R122H, N29I, K23R, A16V and D22G, in the cationic trypsinogen ...
Abstract. Fibrocalculous pancreatitis diabetes (FCPD), a late stage of tropical chronic pancreatitis...
Pancreatitis is considered to be an autodigestive disease due to premature activation of trypsinogen...
Genetic features of chronic pancreatitis (CP) have been investigated extensively, mainly by testing ...
Three-point mutations (R117H, N211, A16V) within the cationic trypsinogen gene have been identified ...
Abstract Genetic features of chronic pancreatitis (CP) have been investigated extensively, mainly by...
In this case report, we present a young patient with type 1 diabetes who had hereditary chronic panc...
Context Mutations in cystic fibrosis transmembrane conductance regulator (CFTR), in cationic trypsin...
Fibrocalculous pancreatic diabetes (FCPD) is a secondary cause of diabetes due to chronic pancreatit...
Fibrocalculous pancreatic diabetes (FCPD) is a form of diabetes associated with tropical chronic cal...
Background: Pancreatitis has a proven genetic basis in a minority of patients. Methods: Review of th...
Fibrocalculous pancreatic diabetes (FCPD) is a secondary cause of diabetes due to chronic pancreatit...
Chronic pancreatitis (CP) is a continuing or relapsing inflammatory disease of the pancreas. In appr...
OBJECTIVE The pathogenesis of chronic pancreatitis (CP) is poorly understood. Genetic studies revea...
OBJECTIVES: Cystic fibrosis transmembrane conductance regulator (CFTR), cationic trypsinogen gene (P...
Several missense mutations, including R122H, N29I, K23R, A16V and D22G, in the cationic trypsinogen ...
Abstract. Fibrocalculous pancreatitis diabetes (FCPD), a late stage of tropical chronic pancreatitis...
Pancreatitis is considered to be an autodigestive disease due to premature activation of trypsinogen...
Genetic features of chronic pancreatitis (CP) have been investigated extensively, mainly by testing ...
Three-point mutations (R117H, N211, A16V) within the cationic trypsinogen gene have been identified ...
Abstract Genetic features of chronic pancreatitis (CP) have been investigated extensively, mainly by...
In this case report, we present a young patient with type 1 diabetes who had hereditary chronic panc...
Context Mutations in cystic fibrosis transmembrane conductance regulator (CFTR), in cationic trypsin...
Fibrocalculous pancreatic diabetes (FCPD) is a secondary cause of diabetes due to chronic pancreatit...
Fibrocalculous pancreatic diabetes (FCPD) is a form of diabetes associated with tropical chronic cal...
Background: Pancreatitis has a proven genetic basis in a minority of patients. Methods: Review of th...
Fibrocalculous pancreatic diabetes (FCPD) is a secondary cause of diabetes due to chronic pancreatit...
Chronic pancreatitis (CP) is a continuing or relapsing inflammatory disease of the pancreas. In appr...
OBJECTIVE The pathogenesis of chronic pancreatitis (CP) is poorly understood. Genetic studies revea...
OBJECTIVES: Cystic fibrosis transmembrane conductance regulator (CFTR), cationic trypsinogen gene (P...
Several missense mutations, including R122H, N29I, K23R, A16V and D22G, in the cationic trypsinogen ...